Nav

news center

news center

Current position Home News

Phoenix network information reported that Chengdu High-tech Zone held precision medicine double innovation competition finals

2022-05-11


011853099546.jpg


Sichuan News Network, Chengdu, September 16 (reporter Chen Lin) focused on "precision medicine science and technology innovation and industrial development", the final of the precision medicine double Innovation Competition was held in Chengdu. After fierce competition in the final, Chengdu Jinxi Technology Co., Ltd. won the first prize of this competition with its unique advantages and wonderful performance of the project "nanopore gene sequencer", Chengdu Weikang Biotechnology Co., Ltd. and Chengdu Salomon Brothers Medical Laboratory won the second prize. Chengdu Shengshi Junlian Biotechnology Co., LTD., Chengdu Fort Hayes Medical Technology Co., LTD., and Chengdu Xinyun Decoding Technology Co., Ltd. won the third prize.

The competition was launched in July, and the project was publicly solicited nationwide through the website, wechat and other channels. As of late August, more than 50 enterprises had signed up, and 6 enterprises entered the final with their projects after the preliminary and semi-final. The final is judged by experts and scholars in the field of precision medicine, representatives of biomedical enterprises and entrepreneurial teams, and well-known experts from investment and financing institutions.

"This competition helps to realize the successful docking and cooperation between high-quality capital and outstanding enterprises and projects in the field of precision medicine, not only to find excellent projects for Tianfu Life Science Park and biomedical innovation Incubator Park, but also to show the good innovation and entrepreneurship environment of Chengdu High-Tech Zone." The relevant person in charge of Chengdu High-tech Zone said that as the core gathering area for the development of biological industry in the province and city, Chengdu High-Tech Zone has vigorously promoted the development and growth of the biological industry in recent years by improving the level of government services, introducing biological industry support policies, and setting up special funds for biological industry.

"We hope to activate the innovation vitality of domestic precision medicine through road show competition, realize the effective link between cutting-edge scientific and technological innovation and clinical transformation, industrial projects and capital, international market and domestic market, and promote the integrated innovation and development of precision medicine ''government, industry, university and research''." The person in charge of Tianfu Life Science and Technology Park introduced that most of the enterprises participating in the registration have leading technologies or patents in the precision medicine industry, with obvious competitive advantages, and are innovative and entrepreneurial enterprises in the rapid growth period. Since the launch of the competition in July, a total of more than 50 enterprises have applied for projects through multiple channels such as the website and wechat. From late August to early September, the preliminary and final rounds of the competition were held, and after layers of selection and assessment, In the end, Chengdu Shengshi Junlian Biotechnology Co., LTD., Chengdu Weikang Biotechnology Co., LTD., Chengdu Salomon Brothers Medical Laboratory, Chengdu Fort Hayes Medical Technology Co., LTD., Chengdu Jinshi Technology Co., LTD., Chengdu Xinyun Decoding Technology Co., LTD. 6 companies stood out and entered the final.

The event invited biomedical experts and scholars in the field of precision medicine such as national "Thousand Talents Plan" experts and Chairman Zhang Zhixin of Yianbo Biology, representatives of biomedical enterprises and entrepreneurial teams and well-known experts from investment and financing institutions to gather together to discuss the opportunities and prospects of precision medicine technological innovation and industrial development. The finals are judged by five professionals in the field of biomedicine, including National Thousand Talents Plan experts, provincial Thousand Talents Plan experts, senior investors, and senior industrial park operation experts, who conduct on-site evaluation, questions and scores on the finalists and their projects.

(Photo from Chengdu High-tech Zone Development Planning Bureau)

Original address: Click to open the link



关闭